A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
Clinical trial NCT04081337 · COMPLETED
Trial details
- NCT number
- NCT04081337
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2022-05-26
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.